FBXW7 and acute lymphoblastic leukemia: Targeting Notch receptor maturation may become a promising therapeutic approach to block Notch signaling in contexts where it functions in a ligand-independent manner due to the activating Notch or inactivating FBXW7 mutations (T-ALL, CLL, and mantle cell lymphoma) [255].